Eli Lilly Corp. buy gerihouse
Summary
This prediction ended on 04.01.16 with a price of €74.84. The BUY prediction by gerihouse finished with a performance of 4.66%. gerihouse has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. gerihouse has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Eli Lilly Corp. | 2.787% | 2.787% | 59.941% | 317.416% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
According to gerihouse what are the pros and cons of Eli Lilly Corp. for the foreseeable future?
Pros
Cons
Comments by gerihouse for this prediction
In the thread Eli Lilly Corp. diskutieren
gerihouse stimmt der fundamentalen Bewertung mit dem Ergebnis 'überbewertet' nicht zu
gerihouse stimmt am 13.10.2015 der fundamentalen Bewertung mit dem Ergebnis überbewertet nicht zu.
Genug gefallen! Einer meiner US Lieblingsaktien!
Credit Suisse upgraded shares of Eli Lilly and (NYSE:LLY) from a neutral rating to an outperform rating in a report issued on Friday morning, The Fly reports. The firm currently has $105.00 target price on the stock, up from their prior target price of $89.00.
A number of other analysts have also recently issued reports on LLY. Leerink Swann reissued an outperform rating and set a $77.00 price target on shares of Eli Lilly and in a report on Thursday, June 11th. Piper Jaffray began coverage on Eli Lilly and in a research note on Wednesday, June 17th. They set an overweight rating and a $97.00 price objective on the stock. Jefferies Group reiterated a buy rating and issued a $100.00 price target on shares of Eli Lilly and in a research note on Wednesday, June 17th. Argus boosted their price objective on Eli Lilly and from $80.00 to $92.00 and gave the stock a buy rating in a research report on Thursday, June 18th. Finally, SunTrust set a $95.00 target price on Eli Lilly and and gave the stock a buy rating in a report on Wednesday, June 24th. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock has an average rating of Buy and an average target price of $94.60.
Current prediction by gerihouse for Eli Lilly Corp.
Eli Lilly Corp.
16.11.23
16.11.24
04.10.24
Stopped prediction by gerihouse for Eli Lilly Corp.
Eli Lilly Corp.
04.11.22
04.11.23
05.11.23
Eli Lilly Corp.
18.01.22
18.01.23
23.09.22
Eli Lilly Corp.
25.01.21
25.01.22
17.01.22
Eli Lilly Corp.
18.03.20
12.10.20
12.10.20
Eli Lilly Corp.
13.10.19
26.10.19
26.10.19
Eli Lilly Corp.
06.09.19
13.10.19
13.10.19
Eli Lilly Corp.
24.06.19
06.09.19
06.09.19
Eli Lilly Corp.
18.04.19
24.05.19
24.05.19
Eli Lilly Corp.
24.01.19
04.04.19
04.04.19
Eli Lilly Corp.
10.05.18
06.09.18
06.09.18
Eli Lilly Corp.
31.08.17
10.11.17
10.11.17
Eli Lilly Corp.
10.11.16
18.04.17
18.04.17
Eli Lilly Corp.
24.03.16
08.08.16
08.08.16
Eli Lilly Corp.
05.05.15
22.07.15
22.07.15
Eli Lilly Corp.
11.09.14
24.11.14
24.11.14
Eli Lilly Corp.
09.10.12
21.02.13
21.02.13
Eli Lilly Corp.
04.07.12
05.09.12
05.09.12